Jarmila Zidkova

Title: Jarmila Zidkova: Innovator in Cancer Diagnosis

Introduction

Jarmila Zidkova is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of cancer diagnosis through her innovative research and development. Her work focuses on the detection of cancer-related autoantibodies, which can play a crucial role in early diagnosis and prognosis.

Latest Patents

Jarmila Zidkova holds a patent for "Systems and methods for diagnosis and prognosis of cancer." This patent describes methods for diagnosing cancer in a subject by determining the amount of autoantibodies that are immunoreactive to procathepsin D (pCD) in a sample obtained from the subject. The systems provided in her patent include an autoantibody immunoreactive pCD antigen and a means for detecting the binding of an autoantibody to the antigen. She has 1 patent to her name.

Career Highlights

Zidkova is affiliated with the University of Louisville Research Foundation, Inc., where she continues her research in cancer diagnostics. Her work has garnered attention for its potential to improve cancer detection methods, ultimately benefiting patient outcomes.

Collaborations

Jarmila has collaborated with notable colleagues, including Vaclav Vetvicka and Martin Fusek, who share her commitment to advancing cancer research.

Conclusion

Jarmila Zidkova's innovative contributions to cancer diagnosis highlight her dedication to improving healthcare through scientific research. Her work exemplifies the impact of inventors in the medical field, paving the way for advancements in cancer detection and treatment.